Drug companies gave at least $116 million to patient advocacy groups in 2015, according to a database launched Friday by Kaiser Health News. “Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration,” KHN writes. “But do they represent patients or Big Pharma? Kaiser Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups. The Pre$cription for Power database will be available for downloading in May. The database currently covers 2015 and will be updated as additional data become available.”

Related News Articles

Headline
Nearly 70 organizations, including the AHA, today urged congressional leaders to advance the House-passed Pandemic and All-Hazards Preparedness…
Perspective
As our country works to expand health coverage and improve access to care, “Medicare for All” is getting a lot of attention. There are many different flavors…
Headline
Reps. Terri Sewell, D-Ala., and John Katko, R-N.Y., today introduced the Resident Physician Shortage Reduction Act of 2019 (H.R. 1763) that would add up to 15,…
Headline
Legislative proposals for a Medicare public option could negatively affect patient access to care and significantly reduce payments to hospitals, AHA Executive…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Blog
Patients should be confident in knowing that their hospital is their lifeline to access care in their community. The cuts proposed today raise serious concerns…